Raj Mehra
2022
In 2022, Raj Mehra earned a total compensation of $2.5M as Chairman, Chief Executive Officer, President at Apricus Biosciences, a 84% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $280,844 |
|---|---|
| Option Awards | $1,603,680 |
| Salary | $561,688 |
| Other | $12,200 |
| Total | $2,458,412 |
Mehra received $1.6M in option awards, accounting for 65% of the total pay in 2022.
Mehra also received $280.8K in non-equity incentive plan, $561.7K in salary and $12.2K in other compensation.
Rankings
In 2022, Raj Mehra's compensation ranked 1,483rd out of 5,756 executives tracked by ExecPay. In other words, Mehra earned more than 74.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,483 out of 5,756 | 74th |
Division Manufacturing | 744 out of 3,133 | 76th |
Major group Chemicals And Allied Products | 290 out of 1,419 | 80th |
Industry group Drugs | 269 out of 1,320 | 80th |
Industry Pharmaceutical Preparations | 192 out of 966 | 80th |
Source: SEC filing on April 12, 2023.
Mehra's colleagues
We found one more compensation record of an executive who worked with Raj Mehra at Apricus Biosciences in 2022.
2022
Michael Golembiewski
Apricus Biosciences
Chief Financial Officer
News
Apricus Biosciences CEO Raj Mehra's 2023 pay falls 30% to $1.7M
August 20, 2024
Apricus Biosciences CEO Raj Mehra's 2022 pay falls 84% to $2.5M
April 12, 2023
Apricus Biosciences CEO Raj Mehra's 2021 pay jumps 270% to $16M
April 12, 2022
Apricus Biosciences CEO Richard Pascoe's 2019 pay rises 15% to $1.2M
April 13, 2020